Evogene Stock Price History

EVGN Stock  USD 1.43  0.05  3.62%   
If you're considering investing in Evogene Stock, it is important to understand the factors that can impact its price. As of today, the current price of Evogene stands at 1.43, as last reported on the 16th of March 2025, with the highest price reaching 1.43 and the lowest price hitting 1.36 during the day. Evogene appears to be very risky, given 3 months investment horizon. Evogene secures Sharpe Ratio (or Efficiency) of 0.05, which denotes the company had a 0.05 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Evogene, which you can use to evaluate the volatility of the firm. Please utilize Evogene's Mean Deviation of 3.62, coefficient of variation of 2001.15, and Downside Deviation of 3.85 to check if our risk estimates are consistent with your expectations.
  
Evogene Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.05

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsEVGN
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 4.97
  actual daily
44
56% of assets are more volatile

Expected Return

 0.25
  actual daily
4
96% of assets have higher returns

Risk-Adjusted Return

 0.05
  actual daily
3
97% of assets perform better
Based on monthly moving average Evogene is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Evogene by adding it to a well-diversified portfolio.

Evogene Stock Price History Chart

There are several ways to analyze Evogene Stock price data. The simplest method is using a basic Evogene candlestick price chart, which shows Evogene price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJanuary 2, 20251.94
Lowest PriceDecember 18, 20241.24

Evogene March 16, 2025 Stock Price Synopsis

Various analyses of Evogene's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Evogene Stock. It can be used to describe the percentage change in the price of Evogene from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Evogene Stock.
Evogene Price Action Indicator 0.06 
Evogene Price Daily Balance Of Power 0.71 
Evogene Price Rate Of Daily Change 1.04 

Evogene March 16, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Evogene Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Evogene intraday prices and daily technical indicators to check the level of noise trading in Evogene Stock and then apply it to test your longer-term investment strategies against Evogene.

Evogene Stock Price History Data

The price series of Evogene for the period between Mon, Dec 16, 2024 and Sun, Mar 16, 2025 has a statistical range of 0.7 with a coefficient of variation of 10.91. Under current investment horizon, the daily prices are spread out with arithmetic mean of 1.53. The median price for the last 90 days is 1.48. The company completed 1:10 stock split on 25th of July 2024.
OpenHighLowCloseVolume
03/16/2025
 1.36  1.43  1.36  1.43 
03/14/2025 1.36  1.43  1.36  1.43  11,291 
03/13/2025 1.38  1.44  1.37  1.38  27,941 
03/12/2025 1.37  1.42  1.37  1.40  1,497 
03/11/2025 1.37  1.41  1.37  1.41  7,392 
03/10/2025 1.47  1.47  1.39  1.41  12,364 
03/07/2025 1.41  1.49  1.40  1.48  17,484 
03/06/2025 1.43  1.44  1.39  1.41  31,404 
03/05/2025 1.34  1.48  1.34  1.41  30,130 
03/04/2025 1.42  1.42  1.32  1.33  11,474 
03/03/2025 1.44  1.51  1.31  1.41  28,322 
02/28/2025 1.42  1.47  1.42  1.46  6,034 
02/27/2025 1.41  1.48  1.30  1.47  51,854 
02/26/2025 1.42  1.46  1.41  1.41  13,615 
02/25/2025 1.42  1.46  1.38  1.42  38,432 
02/24/2025 1.41  1.42  1.40  1.42  5,633 
02/21/2025 1.38  1.42  1.37  1.42  17,467 
02/20/2025 1.46  1.47  1.37  1.38  28,136 
02/19/2025 1.48  1.49  1.46  1.47  8,975 
02/18/2025 1.52  1.52  1.48  1.48  18,634 
02/14/2025 1.48  1.55  1.47  1.55  10,024 
02/13/2025 1.52  1.54  1.46  1.48  42,424 
02/12/2025 1.48  1.54  1.46  1.47  9,155 
02/11/2025 1.55  1.56  1.49  1.49  14,742 
02/10/2025 1.48  1.56  1.48  1.56  34,951 
02/07/2025 1.55  1.58  1.44  1.46  18,493 
02/06/2025 1.47  1.64  1.46  1.56  29,771 
02/05/2025 1.50  1.53  1.43  1.45  22,319 
02/04/2025 1.49  1.55  1.45  1.47  20,639 
02/03/2025 1.51  1.53  1.45  1.47  22,313 
01/31/2025 1.64  1.64  1.50  1.57  17,851 
01/30/2025 1.59  1.65  1.51  1.55  9,812 
01/29/2025 1.56  1.65  1.53  1.57  32,725 
01/28/2025 1.58  1.58  1.53  1.54  16,971 
01/27/2025 1.58  1.72  1.52  1.56  28,275 
01/24/2025 1.70  1.72  1.60  1.66  18,436 
01/23/2025 1.76  1.77  1.60  1.67  33,455 
01/22/2025 1.80  1.83  1.76  1.80  30,014 
01/21/2025 1.80  1.84  1.77  1.81  42,409 
01/17/2025 1.71  1.83  1.66  1.78  44,790 
01/16/2025 1.61  1.69  1.60  1.61  34,524 
01/15/2025 1.59  1.63  1.51  1.60  30,432 
01/14/2025 1.58  1.61  1.50  1.52  13,947 
01/13/2025 1.56  1.57  1.45  1.55  30,381 
01/10/2025 1.68  1.68  1.52  1.57  64,180 
01/08/2025 1.75  1.75  1.60  1.66  55,754 
01/07/2025 1.83  1.83  1.75  1.76  39,459 
01/06/2025 1.89  1.90  1.81  1.85  35,557 
01/03/2025 1.93  1.95  1.77  1.90  68,644 
01/02/2025 1.95  1.98  1.92  1.94  25,872 
12/31/2024 2.00  2.01  1.82  1.87  90,920 
12/30/2024 1.77  1.96  1.75  1.92  231,874 
12/27/2024 1.75  1.75  1.60  1.65  81,714 
12/26/2024 1.47  1.74  1.47  1.69  136,795 
12/24/2024 1.38  1.50  1.38  1.45  79,683 
12/23/2024 1.41  1.44  1.33  1.35  64,679 
12/20/2024 1.30  1.44  1.30  1.35  129,007 
12/19/2024 1.27  1.32  1.20  1.29  40,122 
12/18/2024 1.24  1.28  1.23  1.24  34,918 
12/17/2024 1.31  1.33  1.22  1.27  48,079 
12/16/2024 1.35  1.37  1.27  1.32  39,499 

About Evogene Stock history

Evogene investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Evogene is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Evogene will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Evogene stock prices may prove useful in developing a viable investing in Evogene
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel. Evogene operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 133 people.

Evogene Stock Technical Analysis

Evogene technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Evogene technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Evogene trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Backtesting Now

   

Portfolio Backtesting

Avoid under-diversification and over-optimization by backtesting your portfolios
All  Next Launch Module

Evogene Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Evogene's price direction in advance. Along with the technical and fundamental analysis of Evogene Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Evogene to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Evogene offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evogene's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evogene Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evogene Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evogene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
To learn how to invest in Evogene Stock, please use our How to Invest in Evogene guide.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evogene. If investors know Evogene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evogene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Evogene is measured differently than its book value, which is the value of Evogene that is recorded on the company's balance sheet. Investors also form their own opinion of Evogene's value that differs from its market value or its book value, called intrinsic value, which is Evogene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evogene's market value can be influenced by many factors that don't directly affect Evogene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evogene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evogene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evogene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.